These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3294879

  • 1. Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources.
    Sasaki A, Sato S, Murakami O, Go M, Inoue M, Shimizu Y, Hanew K, Andoh N, Sato I, Sasano N.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):176-82. PubMed ID: 3294879
    [Abstract] [Full Text] [Related]

  • 2. Immunoreactive corticotropin-releasing factor in human plasma.
    Suda T, Tomori N, Yajima F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K.
    J Clin Invest; 1985 Nov; 76(5):2026-9. PubMed ID: 2997301
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery.
    Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, Go M, Shimizu Y, Hanew K, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):224-9. PubMed ID: 3491832
    [Abstract] [Full Text] [Related]

  • 4. Immunoreactive corticotropin-releasing factor in rat plasma.
    Sumitomo T, Suda T, Tomori N, Yajima F, Nakagami Y, Ushiyama T, Demura H, Shizume K.
    Endocrinology; 1987 Apr; 120(4):1391-6. PubMed ID: 3030699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 7. Correlation between plasma levels of ACTH and cortisol in basal states and during the CRH test in normal subjects and patients with hypothalamo-pituitary disorders.
    Bando H, Zhang CY, Takada Y, Takahashi H, Yamasaki R, Saito S.
    Tokushima J Exp Med; 1991 Dec; 38(3-4):61-9. PubMed ID: 1668824
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma levels of corticotropin-releasing hormone in hypothalamic-pituitary-adrenal disorders and chronic renal failure.
    Hashimoto K, Nishioka T, Numata Y, Ogasa T, Kageyama J, Suemaru S.
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):503-7. PubMed ID: 8393256
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]

  • 11. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y, Niinomi M, Takatsuki K, Oiso Y, Tomita A.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 14. CRH in Cushing's syndrome.
    Müller OA, Stalla GK, von Werder K.
    Horm Metab Res Suppl; 1987 Jul; 16():51-8. PubMed ID: 2832289
    [Abstract] [Full Text] [Related]

  • 15. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
    Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.
    Kashio Y, Chihara K, Kita T, Okimura Y, Sato M, Kadowaki S, Fujita T.
    J Clin Endocrinol Metab; 1987 Jan; 64(1):92-7. PubMed ID: 3097059
    [Abstract] [Full Text] [Related]

  • 19. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, Grossman AB.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.